Beigene Ltd
HKEX:6160

Watchlist Manager
Beigene Ltd Logo
Beigene Ltd
HKEX:6160
Watchlist
Price: 194.3 HKD 5.31% Market Closed
Market Cap: 264.8B HKD

Relative Value

The Relative Value of one Beigene Ltd stock under the Base Case scenario is hidden HKD. Compared to the current market price of 194.3 HKD, Beigene Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Beigene Ltd Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
66
vs Industry
47
Median 3Y
7.4
Median 5Y
7.8
Industry
8
Forward
6.6
vs History
vs Industry
Median 3Y
-24.1
Median 5Y
-20.3
Industry
23.5
Forward
113.8
vs History
14
vs Industry
Median 3Y
-17.4
Median 5Y
-18
Industry
21.9
vs History
9
vs Industry
Median 3Y
-13.9
Median 5Y
-15.2
Industry
24.3
vs History
17
vs Industry
11
Median 3Y
5.9
Median 5Y
5.4
Industry
3.2
vs History
65
vs Industry
40
Median 3Y
6.9
Median 5Y
7.4
Industry
8.1
Forward
6.2
vs History
66
vs Industry
41
Median 3Y
8.1
Median 5Y
8.6
Industry
10.1
vs History
4
vs Industry
23
Median 3Y
-13.3
Median 5Y
-13.5
Industry
5.9
Forward
59.8
vs History
4
vs Industry
21
Median 3Y
-13.3
Median 5Y
-13.5
Industry
6.2
Forward
87.4
vs History
14
vs Industry
23
Median 3Y
-15.2
Median 5Y
-16.1
Industry
7.7
vs History
9
vs Industry
22
Median 3Y
-10.9
Median 5Y
-11.5
Industry
6.3
vs History
20
vs Industry
19
Median 3Y
9
Median 5Y
8.5
Industry
5.6

Multiples Across Competitors

Competitors Multiples
Beigene Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Beigene Ltd
HKEX:6160
277.5B HKD 7 -1 628.2 231.6 231.6
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 837 682.7 -160 825.5 -195 293.4 -193 064.9
US
Abbvie Inc
NYSE:ABBV
389.1B USD 6.5 165.7 16.1 22.8
US
Amgen Inc
NASDAQ:AMGN
172B USD 4.8 24.6 17.8 17.8
US
Gilead Sciences Inc
NASDAQ:GILD
145.7B USD 5 18 12 12
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
113.1B USD 9.6 30.8 22.5 23.5
US
Epizyme Inc
F:EPE
94.1B EUR 2 082 -531.3 -578.5 -563.1
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
79.9B USD 5.6 17.4 16.6 18.8
AU
CSL Ltd
ASX:CSL
83.5B AUD 3.6 18.6 12.6 15.7
NL
argenx SE
XBRU:ARGX
44.1B EUR 14.3 33.7 58.1 59.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
51.4B USD 16 1 180.3 159.1 193
P/E Multiple
Earnings Growth PEG
CN
Beigene Ltd
HKEX:6160
Average P/E: 186.1
Negative Multiple: -1 628.2
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -160 825.5 N/A N/A
US
Abbvie Inc
NYSE:ABBV
165.7
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
24.6
45%
0.5
US
Gilead Sciences Inc
NASDAQ:GILD
18
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
30.8
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -531.3 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.4
10%
1.7
AU
CSL Ltd
ASX:CSL
18.6
11%
1.7
NL
argenx SE
XBRU:ARGX
33.7
40%
0.8
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 180.3
N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CN
Beigene Ltd
HKEX:6160
Average EV/EBITDA: 60.7
231.6
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -195 293.4 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.1
14%
1.1
US
Amgen Inc
NASDAQ:AMGN
17.8
11%
1.6
US
Gilead Sciences Inc
NASDAQ:GILD
12
7%
1.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
22.5
16%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -578.5 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.6
11%
1.5
AU
CSL Ltd
ASX:CSL
12.6
8%
1.6
NL
argenx SE
XBRU:ARGX
58.1
810%
0.1
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
159.1
N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CN
Beigene Ltd
HKEX:6160
Average EV/EBIT: 66.1
231.6
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -193 064.9 N/A N/A
US
Abbvie Inc
NYSE:ABBV
22.8
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
17.8
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12
12%
1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.5
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -563.1 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.8
13%
1.4
AU
CSL Ltd
ASX:CSL
15.7
11%
1.4
NL
argenx SE
XBRU:ARGX
59.7
N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
193
N/A N/A